Detalhe da pesquisa
1.
Dual κ-agonist/µ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease.
Ann Neurol
; 77(6): 930-41, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25820831
2.
CCR3 plays a role in murine age-related cognitive changes and T-cell infiltration into the brain.
Commun Biol
; 6(1): 292, 2023 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934154
3.
Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.
J Neurosci
; 31(19): 6963-71, 2011 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21562258
4.
α-Synuclein phosphorylation as a therapeutic target in Parkinson's disease.
Rev Neurosci
; 23(2): 191-8, 2012 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22499677
5.
Molecular and histological correlates of cognitive decline across age in male C57BL/6J mice.
Brain Behav
; 12(9): e2736, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971662
6.
Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease.
Neurobiol Dis
; 39(3): 311-7, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20451607
7.
Aging: therapeutics for a healthy future.
Neurosci Biobehav Rev
; 108: 453-458, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31783058
8.
Plasma-Based Strategies for Therapeutic Modulation of Brain Aging.
Neurotherapeutics
; 16(3): 675-684, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161489
9.
Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial.
JAMA Neurol
; 76(1): 35-40, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383097
10.
Rapid and differential regulation of AMPA and kainate receptors at hippocampal mossy fibre synapses by PICK1 and GRIP.
Neuron
; 37(4): 625-38, 2003 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12597860
11.
Synaptic plasticity: one STEP at a time.
Trends Neurosci
; 29(8): 452-8, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16806510
12.
Expression and function of striatal enriched protein tyrosine phosphatase is profoundly altered in cerebral ischemia.
Eur J Neurosci
; 27(9): 2444-52, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18445231
13.
Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
J Neuropathol Exp Neurol
; 77(2): 139-148, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29281045
14.
A Guide to Single-Cell Transcriptomics in Adult Rodent Brain: The Medium Spiny Neuron Transcriptome Revisited.
Front Cell Neurosci
; 12: 159, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29970990
15.
Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies.
Ann Clin Transl Neurol
; 3(10): 769-780, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27752512
16.
A pharmacological screening approach for discovery of neuroprotective compounds in ischemic stroke.
PLoS One
; 8(7): e69233, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23874920
17.
Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease.
Neurotherapeutics
; 10(1): 143-53, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23296837
18.
Protein phosphatases and Alzheimer's disease.
Prog Mol Biol Transl Sci
; 106: 343-79, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22340724
19.
Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease.
Neurochem Int
; 61(6): 899-906, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22342821
20.
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease.
Future Med Chem
; 3(7): 821-33, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21644827